Statistics
Publications
6
Citations
331
H-Index
6
Active since
2016
Kay Shigemori is an author at Dana-Farber Cancer Institute specializing in medicine, molecular oncology, and oncology.
Publications per year
2016–2020
6
6
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas
Raphael Koch, Amanda L. Christie, Jennifer L. Crombie et al. · Blood · 2018 · 63 citations · Full text
Medicine, Immunology, Oncology +16
Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents
Chen Lossos, Yunpeng Liu, Kellie E. Kolb et al. · Cancer Discovery · 2019 · 59 citations · Full text
Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions
Noriaki Yoshida, Kay Shigemori, Nicholas L. Donaldson et al. · Blood · 2020 · 34 citations · Full text
1–5 of 6